Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...
1d
Zacks.com on MSNMerck (MRK) Stock Drops Despite Market Gains: Important Facts to NoteThe most recent trading session ended with Merck (MRK) standing at $93.43, reflecting a -1.37% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...
1d
Zacks Investment Research on MSNMerck (MRK) Is Considered a Good Investment by Brokers: Is That True?When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
Molson Coors, Merck & Co. and Deutsche Telekom are part ... yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall Street analysts with ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma ...
New growth drivers, including updates from its extensive clinical pipeline, could help the stock to rebound. As of this writing, Merck's stock is down 16% year to date, hovering near its lowest ...
In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results